Soc. Generale Knock-Out RAA/ DE000SH03V94 /
12/06/2024 08:19:18 | Var.0.000 | Denaro09:30:57 | Lettera09:30:57 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.570EUR | 0.00% | 0.550 Quantità in denaro: 15,000 |
0.560 Quantità in lettera: 15,000 |
RATIONAL AG | 1,095.9584 EUR | 31/12/2078 | Put |
GlobeNewswire
10:00
Intech Unveils UCITS Fund with Adaptive Volatility and ESG Focus, Anchored by Norway’s Pension Schem...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation I...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
MBUU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Malibu Boats, Inc. Investors w...
GlobeNewswire
10:00
BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patient...
GlobeNewswire
09:01
AMERICAN SALARS COMPLETES PHASE 1 EXPLORATION OF BLACK ROCK SOUTH LITHIUM BRINE PROJECT, NV
GlobeNewswire
09:00
Nokia Report reveals enterprises are scaling private wireless for additional uses cases and industri...
GlobeNewswire
08:55
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...